Biogen Inc. (BIIB) vs Humana Inc. (HUM)
BIIB leads on 11 of 15 compared metrics.
A side-by-side comparison of Biogen Inc. and Humana Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 18, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BIIB vs HUM
growth of $100 · last 30yBIIB +4919.0%HUM +1805.3%BIIB compounded faster
BIIB HUM
BIIB vs HUM: by the numbers
- •HUM is the larger company ($43.46B vs $29.33B market cap).
- •BIIB trades at the lower earnings multiple (21.27 vs 38.72 P/E).
- •BIIB converts more revenue to profit (13.92% vs 0.82% net margin).
- •HUM grew revenue faster over the past five years (11.71% vs -4.80% CAGR).
- •HUM pays a dividend (0.98% yield) while BIIB does not currently pay one.
Which is better, BIIB or HUM?
Metric tally: BIIB 11 · HUM 4It depends on what you're optimizing for:
ValueBIIB(lower P/E)
GrowthHUM(faster 5Y revenue CAGR)
QualityBIIB(higher ROIC)
Metrics side by side
Valuation
| Metric | BIIB | HUM |
|---|---|---|
| P/E ratio | 21.27● | 38.72 |
| Forward P/E | 12.18● | 22.85 |
| P/S ratio | 2.99 | 0.32● |
| P/B ratio | 1.58● | 2.35 |
| EV / EBITDA | 12.09● | 18.49 |
| FCF yield | 8.90%● | 2.91% |
Profitability
| Metric | BIIB | HUM |
|---|---|---|
| Gross margin | 69.77%● | 14.01% |
| Operating margin | 15.65%● | 1.01% |
| Net margin | 13.92%● | 0.82% |
| ROE | 7.36%● | 6.08% |
| ROIC | 6.62%● | 3.12% |
Dividends
| Metric | BIIB | HUM |
|---|---|---|
| Dividend yield | — | 0.98% |
| Payout ratio | — | 35.87% |
Growth (annualized)
| Metric | BIIB | HUM |
|---|---|---|
| Revenue CAGR (5Y) | -4.80% | 11.71%● |
| EPS CAGR (5Y) | -18.67% | -17.27%● |
| FCF CAGR (5Y) | -3.59%● | -17.19% |
| Total return CAGR (5Y) | -12.33% | -2.38%● |
Frequently asked
- Which is better, BIIB or HUM?
- It depends on your goal. value: BIIB (lower P/E); growth: HUM (faster 5Y revenue CAGR); quality: BIIB (higher ROIC). Across all compared metrics, BIIB leads 11 to 4.
- Is BIIB or HUM cheaper?
- On trailing earnings, BIIB is cheaper: BIIB trades at a 21.27 P/E and HUM at 38.72.
- Which has grown faster, BIIB or HUM?
- Over the past five years, HUM grew revenue faster — BIIB at a -4.80% CAGR versus HUM at 11.71%.
- Does BIIB or HUM pay a bigger dividend?
- HUM pays a dividend (0.98% yield) while BIIB does not currently pay one.
- Is BIIB or HUM more profitable?
- BIIB runs the higher net margin — BIIB at 13.92% versus HUM at 0.82%.
- Which has been the better investment, BIIB or HUM?
- Over the past 10-year, HUM delivered the higher annualized total return — BIIB at -1.80% versus HUM at 7.72%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Biogen P/E ratioHumana P/E ratioBiogen dividend yieldHumana dividend yieldBiogen ROEHumana ROEBiogen operating marginHumana operating marginBiogen revenue growthHumana revenue growthBiogen free cash flowHumana free cash flow
Biogen & Humana appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 18, 2026.